DiaGenic ASA (DIAG) - Product Pipeline Analysis, 2013 Update - New Market Research Report

DiaGenic ASA (DiaGenic) is a life sciences company. The company operates through one segment, which is research, development, sales and marketing of blood based gene expression tests. It develops blood based biomarkers for premature detection of Alzheimer's disease. DiaGenic develops products for unmet needs related to Alzheimer's diagnosis and treatment. The company makes vitro diagnostic (IVD) products and is emphasizing IVD biomarker products in the field of Alzheimer's disease (AD). DiaGenic plans to develop this product, MCItect, awaiting FDA clearance. The company has expertise in recognizing gene expression signatures in blood. It also follows progress of two additional AD products; a new generation ADtect for the exposure of mild to moderate Alzheimer's disease, and AMYtect used for brain amyloid detection. The company's chief markets include the US, Europe and Japan. DiaGenic is headquartered in Oslo, Norway.

Full Report Details at
- http://www.fastmr.com/prod/652429_diagenic_asa_diag_product_pipeline_analysis_2013.aspx?afid=303

This report is a source for data, analysis and actionable intelligence on the DiaGenic ASA portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- GE Healthcare - Product Pipeline Analysis , 2013 Update
- Philips Healthcare - Product Pipeline Analysis, 2013 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis, 2013 Update
- Siemens Healthcare - Product Pipeline Analysis, 2013 Update